Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-04-07 4:31 pm Unchanged | 2021-04-01 | 13G | Atea Pharmaceuticals, Inc. AVIR | RA Capital Management, L.P. | 5,368,451 6.500% | 0 (Unchanged) | Filing History |
| 2021-03-10 09:46 am Purchase | 2021-03-09 | 13G | Atea Pharmaceuticals, Inc. AVIR | FMR LLC | 8,586,035 10.392% | 2,138,344 (+33.16%) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | RA Capital Management, L.P. | 5,368,451 6.500% | 5,368,451 (New Position) | Filing History |
| 2021-02-16 4:19 pm Purchase | 2020-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | Morningside Venture Investments Limited | 6,634,956 8.030% | 6,634,956 (New Position) | Filing History |
| 2021-02-16 3:33 pm Sale | 2020-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | Cormorant Asset Management, LP | 6,411,355 7.760% | -475,000 (-6.90%) | Filing History |
| 2021-02-10 4:31 pm Purchase | 2020-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | JPM Partners LLC | 6,801,664 8.200% | 6,801,664 (New Position) | Filing History |
| 2021-02-08 10:15 am Purchase | 2021-02-05 | 13G | Atea Pharmaceuticals, Inc. AVIR | FMR LLC | 6,447,691 7.804% | 6,447,691 (New Position) | Filing History |